March6 Protects Against Acute Kidney Injury by Suppressing Renal Tubular Epithelial Cell Ferroptosis Through the Destabilization of P53 and ACSL4 Proteins
Related Experiment Video
Updated: Jan 18, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Jie Feng1, Ranran Kong2, Yi Yang3
1Department of Nephrology, the First Affiliated Hospital of Xi'an Jiaotong University, No. 277 Yanta West Road, Xi'an, 710061, Shaanxi Province, China. fengj04xjtufh@163.com.
Abstract:
Acute kidney injury (AKI) progression involves significant contributions from renal tubular epithelial cell ferroptosis. Membrane associated RING finger protein 6 (March6) is implicated in modulating ferroptosis by regulating the stability of related proteins, yet its specific role in tubular epithelial cell ferroptosis and AKI progression remains unknown. This work seeks to clarify the regulatory role of March6 in the ferroptosis of tubular epithelial cells and its involvement in AKI using ischemia-reperfusion injury (IRI)-induced animal models and hypoxia/reoxygenation (H/R)-induced cellular models. Our results demonstrated a significant reduction in March6 expression in renal tissues from IRI mice and H/R cells, accompanied by elevated PTGS2 and reduced GPX4 levels, two ferroptosis marker proteins. Overexpression of March6 in HK-2 cells significantly counteracted Erastin-induced ferroptosis, whereas silencing March6 increased susceptibility. In H/R models, March6 overexpression enhanced cell viability and lowered cell death, reversing ferroptosis-related changes, whereas silencing March6 exhibited the opposite effects. Tubular-specific overexpression of March6 in mice with IRI-induced AKI notably mitigated kidney damage and suppressed ferroptotic changes. Mechanistically, March6 inhibited ferroptosis by accelerating the degradation of key pro-ferroptotic proteins ACSL4 and p53. Co-immunoprecipitation (Co-IP) experiments validated the direct interaction between March6 and p53 or ACSL4. Overexpressing ACSL4 or p53 in March6-overexpressing HK-2 cells markedly reversed March6's protective effects against H/R-induced damage and ferroptosis. Collectively, March6 mitigates ferroptosis in renal tubular epithelial cells by promoting the degradation of ACSL4 and p53, thereby alleviating AKI progression. This study not only uncovers a novel regulatory mechanism of tubular epithelial cell ferroptosis in AKI but also provides a potential therapeutic target for its treatment.
Insights
Membrane associated RING finger protein 6 (March6) protects against acute kidney injury (AKI) by reducing ferroptosis in renal tubular cells. March6 achieves this by degrading ACSL4 and p53, offering a potential therapeutic target for AKI.
Area of Science:
- Nephrology
- Cell Biology
- Biochemistry
Background:
- Acute kidney injury (AKI) progression is linked to ferroptosis in renal tubular epithelial cells.
- The role of Membrane associated RING finger protein 6 (March6) in tubular cell ferroptosis and AKI is not well understood.
Purpose of the Study:
- To investigate the regulatory role of March6 in renal tubular epithelial cell ferroptosis.
- To determine March6's involvement in AKI progression using animal and cellular models.
Main Methods:
- Utilized ischemia-reperfusion injury (IRI)-induced AKI mouse models and hypoxia/reoxygenation (H/R)-induced cellular models.
- Assessed March6 expression, ferroptosis markers (PTGS2, GPX4), and cell viability.
- Investigated March6's mechanism by examining its interaction with ACSL4 and p53 using co-immunoprecipitation (Co-IP) and gene manipulation.
Main Results:
- March6 expression was reduced in IRI mice and H/R cells, correlating with ferroptosis markers.
- March6 overexpression protected against ferroptosis and cell death in vitro and in vivo.
- March6 inhibited ferroptosis by promoting the degradation of ACSL4 and p53, confirmed by Co-IP and rescue experiments.
Conclusions:
- March6 mitigates renal tubular epithelial cell ferroptosis by enhancing ACSL4 and p53 degradation.
- March6 plays a protective role in AKI progression.
- March6 represents a potential therapeutic target for AKI treatment.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations

